QoL Assessment in Traditional Glaucoma Surgery and MIGS.
NCT ID: NCT03613233
Last Updated: 2018-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2018-01-01
2020-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options
NCT07303257
Multicentric Observational Study on Quality of Life in Glaucoma
NCT01742104
Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.
NCT06865235
Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications
NCT01511094
Trabeculectomy Versus Canaloplasty to Treat Glaucoma
NCT00854256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
traditional glaucoma surgery
glaucoma procedures such as trabeculectomy, iridencleisis, non - penetrating deep sclerectomy
Glaucoma surgery
phacoemulsification
microinvasive glaucoma surgery (MIGS)
glaucoma procedures such as : canaloplasty (traditional, ABiC, modified), iStent, XEN, Cypass,Hydrus- and with any other microinvasive IOP reducing device
Glaucoma surgery
phacoemulsification
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glaucoma surgery
phacoemulsification
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients not tolerating antiglaucoma medications,
* patients with poor compliance
* progression in visual field
Exclusion Criteria
* pregnancy
* mental disease or emotional instability
* general steroid therapy
* inability to fill in the questionnaire
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Military Institute od Medicine National Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marek Rekas
płk prof. Marek RĘKAS, MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Military Institute of Medicine
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0000000417
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.